Antimicrobial prophylaxis with ceftriaxone in renal transplantation. Prospective study of 170 patients.
Due to their uremic state and altered host response induced by immunodepressive therapy, renal transplant recipients are particularly susceptible to infectious complications with high morbidity and mortality. We here report the results of a prospective study with 170 renal transplant patients, undertaken to evaluate the efficacy of ceftriaxone in the prevention of wound and early urinary tract infection. No wound infection was observed, however, 12 patients (7.1%) developed urinary tract infections. On the basis of these data, we recommend ceftriaxone prophylaxis as a safe and effective measure to prevent transplant wound infection and to reduce the incidence of postoperative urinary tract infection.
Institute of General Surgery and Organ Transplantations, University of Parma, Italy.
E
E
Capocasale
M P
MP
Mazzoni
S
S
Tondo
G
G
D'Errico
D000328:Adult; D001424:Bacterial Infections / Q000517:prevention & control*; D002443:Ceftriaxone / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D016030:Kidney Transplantation; D008297:Male; D011446:Prospective Studies; D013530:Surgical Wound Infection / Q000517:prevention & control*; D014552:Urinary Tract Infections / Q000517:prevention & control*
D002443:Ceftriaxone